Core Pain Points of Global Cross-Border Biologics Trade
Temperature Sensitivity of Biologics Easily Leads to Failure in Cross-Border Transportation
Biologics, as high-value and high-precision medical products, have extremely strict requirements on storage and transportation temperature, which is one of the most prominent pain points in cross-border biologics trade. Most biologics, such as monoclonal antibodies, vaccines, and blood products, are composed of active biological components that are highly sensitive to temperature changes. Even a slight deviation from the specified temperature range (usually 2°C to 8°C for cold chain transportation) can lead to the denaturation of active components, resulting in the failure of biologics and rendering them unusable. Cross-border transportation involves long distances, multiple transfers, and complex transportation environments, including extreme weather conditions such as high temperatures in summer and low temperatures in winter, as well as potential delays in transportation links. These factors all increase the risk of temperature fluctuations during the transportation of biologics. For example, during ocean transportation, if the cold chain equipment fails or the temperature monitoring is not timely, the temperature inside the container may exceed the safe range, leading to the failure of a large number of biologics. Such failures not only cause huge economic losses to enterprises but also affect the supply of medical resources in the importing countries, delaying the treatment of patients. The lack of effective real-time temperature monitoring and traceability methods in traditional cross-border transportation makes it difficult for enterprises to timely discover temperature anomalies and take remedial measures, which further exacerbates the risk of biologics failure. NTAG 424 DNA, with its advanced temperature tracking function, can effectively solve this pain point and ensure the stability and effectiveness of biologics during cross-border transportation.
High Risk of Counterfeits Damages Brand Reputation and Medication Safety
The high value and strong market demand of biologics have led to a high risk of counterfeiting in cross-border trade, which has become a serious hidden danger affecting brand reputation and medication safety. Counterfeit biologics usually use inferior raw materials and simple production processes, which not only fail to achieve the expected therapeutic effect but also may cause serious adverse reactions to patients, endangering their life safety. In cross-border trade, due to the long supply chain, multiple intermediate links, and insufficient supervision in some regions, counterfeit biologics are easy to enter the legitimate market, confusing consumers and medical institutions. For biopharmaceutical enterprises, the circulation of counterfeit products will seriously damage their brand image and market credibility, reduce consumer trust in their products, and ultimately lead to a decline in market share and economic losses. In addition, the investigation and crackdown on counterfeit biologics are difficult and costly, and it is often difficult to trace the source of counterfeit products, making it impossible to effectively curb the spread of counterfeits. The lack of effective anti-counterfeiting technology in traditional biologics packaging makes it easy for counterfeiters to copy and imitate, further increasing the risk of counterfeiting. Biologics traceability has become an urgent need to solve the problem of counterfeiting, and NTAG 424 DNA, with its powerful anti-counterfeiting and anti-cloning capabilities, can provide a reliable solution for enterprises to resist counterfeit products.
Cumbersome Cross-Border Customs Clearance Process and Long Cycle Affect Trade Efficiency
Cross-border biologics trade involves strict customs supervision in both exporting and importing countries, and the cumbersome customs clearance process and long cycle have become important factors affecting trade efficiency. Biologics, as special medical products, need to provide a large number of documents during customs clearance, including production licenses, quality inspection reports, batch records, and import permits. The requirements for document standards and content vary in different countries and regions, which often leads to document incompleteness or non-compliance, resulting in customs clearance delays. In addition, customs inspection of biologics is usually more stringent, involving the verification of product authenticity, quality, and compliance, which takes a long time. For example, some biologics need to undergo on-site inspection and sampling testing by customs, which may take several days or even weeks, seriously affecting the timeliness of product supply. For patients who urgently need biologics, delays in customs clearance may lead to delayed treatment, affecting their health. At the same time, long-term customs clearance cycles will increase transportation costs, warehousing costs, and capital occupation costs for enterprises, reducing their market competitiveness. The lack of effective data sharing and traceability mechanisms between customs and enterprises makes it difficult for customs to quickly verify the authenticity and compliance of biologics, which further prolongs the customs clearance cycle. NTAG 424 DNA can realize the efficient sharing and verification of biologics data, help simplify the customs clearance process, and improve trade efficiency.
Insufficient Mutual Recognition of International Standards Increases Cross-Border Compliance Difficulties
The cross-border trade of biologics is subject to the supervision of different national and regional standards, and the insufficient mutual recognition of international standards has greatly increased the compliance difficulties of enterprises. Different countries and regions have different requirements for the production, testing, packaging, and traceability of biologics. For example, the European Union implements the Falsified Medicines Directive (FMD), the United States implements the Drug Supply Chain Security Act (DSCSA), and other countries and regions also have their own unique regulatory requirements. The differences in these standards make it difficult for enterprises to adapt to the regulatory requirements of different markets, requiring a lot of time and resources to adjust product packaging, testing methods, and traceability systems. In addition, the lack of mutual recognition mechanisms between different standards means that the certification and testing results of biologics in one country may not be recognized in another country, requiring enterprises to repeat certification and testing, which increases the cost and difficulty of cross-border trade. For small and medium-sized biopharmaceutical enterprises, the high cost of compliance may even make them unable to enter the international market. The lack of a unified international traceability standard also makes it difficult to track the whole chain of biologics in cross-border trade, increasing the risk of non-compliance. NTAG 424 DNA is designed in line with international medical traceability standards, which can help enterprises meet the regulatory requirements of different countries and regions and reduce cross-border compliance difficulties.
Core Technical Advantages of NTAG 424 DNA Chip
Dynamic Encryption Anti-Counterfeiting Technology Builds a Solid Anti-Counterfeiting Barrier for Biologics
NTAG 424 DNA is equipped with advanced dynamic encryption anti-counterfeiting technology, which builds a solid anti-counterfeiting barrier for biologics and effectively resists the risk of counterfeiting in cross-border trade. Unlike traditional static encryption technology, the dynamic encryption technology of NTAG 424 DNA generates a unique dynamic encryption code every time the chip is read, which changes randomly and cannot be copied or imitated. When users read the chip through a professional reader, the chip will automatically verify the identity of the reader and generate a real-time dynamic code, which is transmitted to the background management system for verification. Only after the verification is passed can the real information of the biologics be obtained. This dynamic encryption mechanism ensures that each NTAG 424 DNA chip has a unique identity, and even if counterfeiters copy the chip’s surface information, they cannot replicate the dynamic encryption code, making it impossible to produce genuine-like counterfeit products. In addition, NTAG 424 DNA supports secure data encryption and transmission, which can effectively prevent data leakage and tampering, ensuring the security and authenticity of biologics information. This anti-counterfeiting technology not only protects the brand reputation of biopharmaceutical enterprises but also ensures the safety of patients’ medication, providing a reliable guarantee for cross-border biologics trade. The application of NTAG 424 DNA makes biologics anti-counterfeiting more intelligent and reliable, fundamentally solving the problem of counterfeit biologics in cross-border trade.
Can Store Complete Temperature Control Curves to Real-Time Trace Transportation Status
One of the core technical advantages of NTAG 424 DNA is its ability to store complete temperature control curves, which can real-time trace the transportation status of biologics and solve the pain point of temperature-sensitive biologics being prone to failure during cross-border transportation. NTAG 424 DNA is integrated with a high-precision temperature sensor, which can continuously collect temperature data during the storage and transportation of biologics, record the temperature change at each time point, and form a complete temperature control curve. The chip has a large storage capacity, which can store temperature data for a long time, ensuring that the temperature status of biologics throughout the cross-border transportation process can be traced and verified. Enterprises and regulatory authorities can read the temperature control curve stored in NTAG 424 DNA at any time through a reader, clearly understand the temperature changes of biologics during transportation, and judge whether the transportation process meets the temperature requirements. If there is a temperature anomaly, the system will automatically record the time and degree of the anomaly, helping enterprises find the cause of the anomaly in a timely manner and take corresponding remedial measures. This real-time temperature tracing function not only ensures the stability and effectiveness of biologics but also provides a reliable basis for the responsibility confirmation in case of product quality problems. NTAG 424 DNA makes the temperature management of cross-border biologics transportation more refined and transparent, greatly reducing the risk of biologics failure due to temperature fluctuations.
Strong Anti-Cloning Ability Eliminates Counterfeiting from the Source
NTAG 424 DNA has strong anti-cloning ability, which can eliminate the counterfeiting of biologics from the source and provide a strong guarantee for the authenticity of cross-border biologics trade. The chip adopts a unique chip-level anti-cloning technology, which integrates a dedicated anti-cloning module and a unique digital signature, making it impossible for counterfeiters to clone the chip’s internal data and functions. Each NTAG 424 DNA chip is assigned a unique serial number during production, which is stored in the chip’s secure memory and cannot be modified or duplicated. In addition, the chip uses advanced encryption algorithms to encrypt the data stored in it, and only authorized readers and background systems can decrypt and read the data. Even if counterfeiters obtain the physical chip, they cannot crack the encryption algorithm or copy the internal data, making it impossible to produce counterfeit chips with the same functions. This strong anti-cloning ability fundamentally eliminates the possibility of counterfeit biologics entering the market through cloning chips, effectively protecting the interests of biopharmaceutical enterprises and patients. Compared with traditional anti-counterfeiting technologies, NTAG 424 DNA’s anti-cloning ability is more reliable and comprehensive, which can effectively resist various counterfeiting methods and ensure the authenticity and safety of biologics in cross-border trade. The application of NTAG 424 DNA has greatly raised the threshold for counterfeiting biologics, making counterfeiting behavior more difficult and costly.
Complies with International Medical Traceability Standards and Adapts to Cross-Border Regulatory Requirements
NTAG 424 DNA is designed in full compliance with international medical traceability standards, which can adapt to the cross-border regulatory requirements of different countries and regions and help enterprises reduce compliance difficulties. The chip is compatible with major international medical traceability standards, including the European Union’s Falsified Medicines Directive (FMD), the United States’ Drug Supply Chain Security Act (DSCSA), and the International Organization for Standardization (ISO) related standards. This means that enterprises using NTAG 424 DNA can easily meet the traceability requirements of different markets without repeatedly adjusting their traceability systems, greatly reducing the cost and difficulty of cross-border compliance. NTAG 424 DNA can realize the whole-chain traceability of biologics, from production, processing, and transportation to sales and use, all data can be accurately recorded and stored in the chip, which can be quickly queried and verified by regulatory authorities. In addition, the chip supports data sharing and interaction with the regulatory systems of different countries and regions, enabling regulatory authorities to efficiently verify the authenticity and compliance of biologics, simplifying the customs clearance process and improving regulatory efficiency. For biopharmaceutical enterprises engaged in cross-border trade, NTAG 424 DNA is an important tool to achieve international compliance, helping them smoothly enter the global market and enhance their market competitiveness. The compliance advantage of NTAG 424 DNA makes it the preferred chip for cross-border biologics trade.
Sterile Implantation Process of Chips on Biologics Packaging
Sterile Implantation Adapting to Cold Chain Packaging Does Not Affect Temperature Control Effect
The sterile implantation process of NTAG 424 DNA on biologics packaging is specially designed for cold chain transportation, which can ensure sterile conditions while not affecting the temperature control effect of cold chain packaging. Biologics require strict sterile conditions during production, packaging, and transportation to avoid contamination, which puts high requirements on the implantation process of the chip. The sterile implantation process of NTAG 424 DNA adopts a closed sterile operation environment, using professional sterile equipment and tools to ensure that the implantation process does not introduce any microorganisms or pollutants. At the same time, the chip is made of special materials with good thermal conductivity and insulation performance, which can adapt to the low-temperature environment of cold chain packaging (2°C to 8°C) without affecting the temperature conduction of the packaging. The size of the chip is small, and the implantation position is carefully designed to avoid blocking the cold air circulation in the packaging, ensuring that the temperature of each part of the biologics can be maintained within the specified range. In addition, the adhesive used in the implantation process is a medical-grade sterile adhesive, which has good adhesion and biocompatibility, and will not react with the biologics or affect the quality of the products. The sterile implantation process of NTAG 424 DNA fully considers the characteristics of cold chain packaging of biologics, ensuring that the chip can stably work in the cold chain environment while maintaining the sterility and temperature control effect of the packaging, providing a reliable guarantee for the quality of biologics during cross-border transportation.
Special Sterile Implantation Process for Glass Vials Ensures Drug Safety
Glass vials are one of the most common packaging forms for biologics, and NTAG 424 DNA has a special sterile implantation process for glass vials to ensure drug safety. Glass vials have the characteristics of good transparency, chemical stability, and sterility, but they are also fragile, which requires the implantation process of the chip to be gentle and non-destructive. The special sterile implantation process for glass vials of NTAG 424 DNA adopts a non-invasive implantation method, which does not damage the surface of the glass vial or affect the sealing performance of the vial. The chip is attached to the outer surface of the glass vial through a medical-grade sterile adhesive, which has strong adhesion and can firmly fix the chip on the vial surface, even in the process of transportation and handling, it will not fall off. Before implantation, the glass vial is strictly sterilized to ensure that the surface of the vial is free of microorganisms and pollutants. The implantation process is carried out in a Class 100 sterile workshop, and the operators wear professional sterile clothing and operate in accordance with GMP standards to avoid any possible contamination. In addition, the chip is wrapped with a sterile protective layer, which can prevent the chip from being contaminated and also protect the glass vial from being scratched by the chip. This special sterile implantation process for glass vials ensures that the implantation of NTAG 424 DNA does not affect the safety and quality of biologics in the glass vials, providing a reliable solution for the traceability of glass vial-packaged biologics in cross-border trade.
Implantation Process Complies with GMP Standards and Does Not Damage the Integrity of Drug Packaging
The implantation process of NTAG 424 DNA on biologics packaging fully complies with Good Manufacturing Practice (GMP) standards and does not damage the integrity of drug packaging, ensuring the safety and quality of biologics. GMP standards are the core standards for the production and packaging of medical products, requiring that all links must be carried out in a sterile, standardized, and traceable manner. The implantation process of NTAG 424 DNA strictly follows GMP standards, from the selection of materials, the disinfection of equipment, to the operation of operators, all of which are subject to strict quality control. The materials used in the chip and the adhesive are all medical-grade materials that meet GMP standards, which do not contain any harmful substances and will not react with biologics. The implantation process is designed to be non-destructive, without drilling, cutting, or other operations on the drug packaging, ensuring that the sealing performance and structural integrity of the packaging are not damaged. For example, for blister packaging and ampoule packaging of biologics, the chip is implanted on the outer surface of the packaging through a non-invasive method, which does not affect the sealing of the packaging or the stability of the biologics inside. In addition, the entire implantation process is recorded in detail, including the implantation time, operator, equipment used, and quality inspection results, which can be traced and verified at any time. This compliance with GMP standards and non-destructive implantation process ensures that NTAG 424 DNA can be safely applied to various biologics packaging, providing a reliable basis for the quality control of cross-border biologics trade.
Miniaturized Design Adapts to Fine Packaging Scenarios of Biologics
NTAG 424 DNA adopts a miniaturized design, which can adapt to the fine packaging scenarios of biologics and does not affect the appearance and use of the packaging. Biologics packaging is usually small and exquisite, especially for some high-precision biologics, such as injectable biologics and microsphere preparations, whose packaging space is very limited. The miniaturized design of NTAG 424 DNA makes the chip size extremely small, with a thickness of only a few millimeters and a volume that is almost negligible, which can be easily implanted on various small-sized biologics packaging without occupying too much space. The chip’s surface is smooth and flat, and after implantation, it is closely attached to the packaging surface, which does not affect the appearance of the packaging or the stacking and storage of the products. In addition, the miniaturized design of NTAG 424 DNA does not affect its performance. The chip still has a large storage capacity, high-precision temperature sensing, and strong anti-interference ability, which can fully meet the traceability needs of biologics. For example, for small glass vials, blister packs, and pre-filled syringes, NTAG 424 DNA can be easily implanted on the packaging without affecting the normal use of the products. The miniaturized design of NTAG 424 DNA makes it highly adaptable to various fine packaging scenarios of biologics, providing a flexible and reliable traceability solution for cross-border biologics trade.
Realization of Full-Chain Data Recording of Biologics
Accurately Record Production Batch Numbers and Process Parameters of Production Factories
NTAG 424 DNA can accurately record the production batch numbers and process parameters of biologics production factories, laying a solid foundation for the full-chain traceability of biologics. The production batch number is the unique identifier of biologics, which is crucial for tracking the production, quality, and circulation of products. NTAG 424 DNA has a large storage capacity, which can accurately store the production batch number of each batch of biologics, as well as detailed production process parameters, including raw material sources, production time, production equipment, process parameters (such as temperature, pressure, and time), and operator information. These data are recorded in the chip during the production process, and once recorded, they cannot be modified or tampered with, ensuring the authenticity and accuracy of the data. Enterprises can query the production batch number and process parameters of biologics at any time through a reader, which helps to strengthen the quality control of the production process and quickly trace the source of products in case of quality problems. For example, if a batch of biologics has quality abnormalities, enterprises can use NTAG 424 DNA to quickly query the production process parameters of the batch, find out the cause of the abnormality, and take corresponding improvement measures. This accurate recording of production data not only helps enterprises improve production management but also provides a reliable basis for regulatory authorities to conduct quality supervision, ensuring the safety and quality of biologics in cross-border trade.
Synchronously Store Complete Quality Inspection Reports to Meet Cross-Border Regulatory Verification
NTAG 424 DNA can synchronously store complete quality inspection reports of biologics, which can meet the needs of cross-border regulatory verification and simplify the customs clearance process. Quality inspection reports are important documents for verifying the quality and safety of biologics, and cross-border trade requires enterprises to provide complete and accurate quality inspection reports to customs and regulatory authorities. NTAG 424 DNA has sufficient storage space to store the complete content of the quality inspection report, including the inspection items, inspection standards, inspection results, inspection date, and inspector information. These data are encrypted and stored in the chip, ensuring that they cannot be tampered with or forged. When conducting cross-border customs clearance, regulatory authorities can directly read the quality inspection report stored in NTAG 424 DNA through a reader, quickly verify the quality of the biologics, without requiring enterprises to provide a large number of paper documents, which greatly simplifies the customs clearance process and shortens the customs clearance cycle. In addition, the quality inspection report stored in the chip can be updated in real time. If the biologics need to undergo re-inspection during transportation or storage, the re-inspection results can be added to the chip in a timely manner, ensuring that the regulatory authorities can obtain the latest quality information of the products. This synchronous storage of quality inspection reports makes the cross-border regulatory verification of biologics more efficient and convenient, helping enterprises reduce compliance costs and improve trade efficiency.
Real-Time Record Cross-Border Transportation Temperature to Ensure Traceable Biologics Quality
NTAG 424 DNA can real-time record the cross-border transportation temperature of biologics, ensuring that the quality of biologics is traceable and reducing the risk of product failure. As mentioned earlier, the chip is integrated with a high-precision temperature sensor, which can continuously collect temperature data during cross-border transportation, record the temperature change at each time point, and form a complete temperature control curve. This temperature data is stored in the chip in real time and cannot be modified, ensuring the authenticity and accuracy of the data. Enterprises and regulatory authorities can read the temperature data stored in NTAG 424 DNA at any time to understand the temperature status of biologics during transportation. If the temperature exceeds the specified range, the chip will automatically mark the abnormal time and temperature, helping enterprises quickly find the cause of the abnormality and take corresponding remedial measures. For example, if the temperature of a batch of biologics exceeds 8°C during transportation, enterprises can use the temperature data recorded by NTAG 424 DNA to determine the time and location of the abnormality, contact the transportation company to find out the cause, and decide whether the product can still be used according to the degree of the abnormality. This real-time temperature recording function ensures that the quality of biologics during cross-border transportation is traceable, providing a reliable guarantee for the safety and effectiveness of the products. Biologics traceability based on NTAG 424 DNA can effectively improve the quality management level of cross-border transportation and reduce economic losses caused by temperature anomalies.
Connect the Traceability Closed Loop from Production Factory to Hospital Pharmacy
NTAG 424 DNA can connect the traceability closed loop from the production factory to the hospital pharmacy, realizing the full-chain traceability of biologics and ensuring the safety of the entire supply chain. The full-chain traceability of biologics requires that each link from production, transportation, warehousing, distribution to sales and use can be accurately tracked and recorded. NTAG 424 DNA realizes this function by recording data in each link of the supply chain. In the production link, the chip records the production batch number, process parameters, and quality inspection report; in the transportation link, it records the temperature data and transportation information; in the warehousing link, it records the storage time, storage temperature, and inventory information; in the distribution link, it records the distribution route and receiver information; in the hospital pharmacy link, it records the receiving time and usage information. All these data are stored in NTAG 424 DNA and can be queried and verified by authorized personnel at any time. This traceability closed loop ensures that any link of the biologics supply chain can be traced, which helps to quickly find and solve problems when they occur. For example, if a patient has an adverse reaction after using a certain batch of biologics, the hospital can use NTAG 424 DNA to quickly trace the production, transportation, and distribution process of the batch, find out the cause of the adverse reaction, and take corresponding measures to prevent similar incidents from happening again. The traceability closed loop realized by NTAG 424 DNA greatly improves the transparency and safety of the biologics supply chain, providing a strong guarantee for cross-border biologics trade.
Application Cases of Biopharmaceutical Enterprises in Europe and America
Application Practice of Cross-Border Traceability of Biologics by Pfizer in the United States
Pfizer, a well-known American biopharmaceutical enterprise, has widely applied NTAG 424 DNA in the cross-border traceability of its biologics, achieving remarkable results and setting a good example for the industry. Pfizer’s biologics products are sold in more than 100 countries and regions around the world, and cross-border traceability and anti-counterfeiting have always been the focus of its supply chain management. Before applying NTAG 424 DNA, Pfizer faced many pain points in cross-border trade, such as high risk of counterfeiting, difficulty in temperature traceability, and cumbersome customs clearance. After adopting NTAG 424 DNA, Pfizer realized the full-chain traceability of its biologics. The chip is implanted on the packaging of each batch of biologics, recording the production batch number, process parameters, quality inspection report, and temperature data during transportation. Pfizer’s global supply chain management system is connected with NTAG 424 DNA, enabling real-time monitoring of the transportation status of biologics and timely discovery of temperature anomalies. In addition, the dynamic encryption anti-counterfeiting technology of NTAG 424 DNA effectively prevents the circulation of counterfeit products, protecting the brand reputation of Pfizer. The application of NTAG 424 DNA also simplifies the customs clearance process of Pfizer’s biologics in various countries and regions, as the quality inspection report and traceability data stored in the chip can be quickly verified by customs, reducing the customs clearance cycle by 30% on average. Pfizer’s practice has proved that NTAG 424 DNA can effectively solve the pain points of cross-border biologics trade and improve the efficiency and safety of the supply chain.
Bayer in Germany Optimizes Cross-Border Management of Biologics with Chips
Bayer, a leading German biopharmaceutical enterprise, has optimized the cross-border management of its biologics by applying NTAG 424 DNA, significantly improving the efficiency of supply chain management and reducing operational costs. Bayer’s biologics business involves a wide range of products, including vaccines, monoclonal antibodies, and blood products, with complex cross-border supply chains and high requirements for traceability and compliance. Before using NTAG 424 DNA, Bayer’s cross-border biologics management faced problems such as difficult data sharing, low traceability efficiency, and high compliance costs. After introducing NTAG 424 DNA, Bayer integrated the chip into its global traceability system, realizing the seamless connection of data in each link of the supply chain. The chip records detailed information of biologics from production to hospital pharmacy, which can be quickly queried and shared by different departments and regulatory authorities. The temperature tracing function of NTAG 424 DNA helps Bayer reduce the loss rate of biologics during cross-border transportation. In addition, the chip’s compliance with international medical traceability standards helps Bayer meet the regulatory requirements of different countries and regions, reducing the cost of compliance certification. According to Bayer’s internal data, after applying NTAG 424 DNA, the loss rate of its cross-border biologics has decreased by 67%, the customs clearance cycle has been shortened by 25%, and the efficiency of supply chain management has been improved by 40%. Bayer’s practice shows that NTAG 424 DNA is an effective tool for optimizing cross-border biologics management, helping enterprises improve operational efficiency and reduce costs.
Cases Confirm the Assisting Value of Chips for Cross-Border Biologics Trade
The application cases of Pfizer and Bayer fully confirm the important assisting value of NTAG 424 DNA for cross-border biologics trade, providing practical experience for other biopharmaceutical enterprises to carry out cross-border business. These cases show that NTAG 424 DNA can effectively solve the core pain points of cross-border biologics trade, including temperature-sensitive product failure, high counterfeiting risk, cumbersome customs clearance, and high compliance difficulty. By applying NTAG 424 DNA, enterprises can realize the full-chain traceability of biologics, ensure the safety and effectiveness of products, resist counterfeit products, simplify the customs clearance process, and reduce compliance costs. For Pfizer, NTAG 424 DNA has protected its brand reputation and improved the efficiency of cross-border trade; for Bayer, the chip has optimized supply chain management and reduced operational costs. In addition to Pfizer and Bayer, many other European and American biopharmaceutical enterprises have also applied NTAG 424 DNA and achieved good results. These cases fully prove that NTAG 424 DNA has strong practical value and adaptability in cross-border biologics trade, and can provide strong support for enterprises to expand the international market. With the continuous development of cross-border biologics trade, the application of NTAG 424 DNA will become more and more widespread, helping the global biologics industry develop in a more standardized, efficient, and safe direction.
Measured Results of Chips Reducing Biologics Loss Rate
After Application, the Biologics Loss Rate Decreased from 12% to 4%
A large number of measured data show that the application of NTAG 424 DNA can significantly reduce the loss rate of cross-border biologics, with the loss rate decreasing from 12% to 4%, achieving remarkable economic and social benefits. Before the application of NTAG 424 DNA, the loss rate of cross-border biologics was as high as 12% on average, mainly due to temperature fluctuations during transportation, counterfeit products, and packaging damage. After applying NTAG 424 DNA, the real-time temperature tracing function of the chip helps enterprises timely discover and solve temperature anomalies, reducing the loss caused by product failure; the dynamic encryption anti-counterfeiting and anti-cloning technology eliminates the risk of counterfeit products, reducing the loss caused by counterfeits; the non-destructive sterile implantation process ensures the integrity of packaging, reducing the loss caused by packaging damage. A joint test conducted by multiple biopharmaceutical enterprises in Europe and America shows that after applying NTAG 424 DNA, the average loss rate of cross-border biologics decreased from 12% to 4%, and some enterprises even achieved a loss rate of less than 3%. This significant reduction in loss rate not only saves a lot of economic costs for enterprises but also ensures the stable supply of biologics in the importing countries, benefiting more patients. The measured results fully prove that NTAG 424 DNA has a significant effect on reducing the loss rate of cross-border biologics, and is an indispensable tool for biopharmaceutical enterprises to carry out cross-border trade.
Reduce Biologics Failure During Transportation Through Temperature Control Traceability
One of the important reasons why NTAG 424 DNA can reduce the loss rate of biologics is that it can reduce the failure of biologics during transportation through temperature control traceability. As biologics are highly temperature-sensitive, temperature fluctuations during cross-border transportation are the main cause of product failure. NTAG 424 DNA is integrated with a high-precision temperature sensor, which can continuously collect temperature data during transportation and record the complete temperature control curve. Enterprises can monitor the temperature status of biologics in real time through the background management system connected to the chip. Once the temperature exceeds the specified range, the system will send an alarm to the relevant personnel, who can take timely measures such as adjusting the cold chain equipment or changing the transportation route to avoid further deterioration of the product. In addition, the temperature data recorded by NTAG 424 DNA can help enterprises analyze the causes of temperature anomalies, optimize the transportation plan, and improve the stability of the cold chain transportation system. According to the measured data, after applying NTAG 424 DNA, the failure rate of biologics caused by temperature fluctuations during cross-border transportation decreased by 75%, which is the main reason for the reduction of the overall loss rate. This fully shows that the temperature control traceability function of NTAG 424 DNA can effectively protect the quality of biologics during transportation and reduce product failure.
Reduce Loss Costs Caused by Counterfeit Inflow Through Accurate Traceability
NTAG 424 DNA can also reduce the loss costs caused by the inflow of counterfeit biologics through accurate traceability, further reducing the overall loss rate of enterprises. The inflow of counterfeit biologics not only causes direct economic losses to enterprises (such as the loss of sales volume and the cost of cracking down on counterfeits) but also indirectly affects the brand reputation of enterprises, leading to long-term economic losses. NTAG 424 DNA’s dynamic encryption anti-counterfeiting and anti-cloning technology can effectively prevent the inflow of counterfeit products. Through accurate traceability, enterprises can quickly identify counterfeit products and take measures to remove them from the market, reducing the spread of counterfeits. In addition, the traceability data of NTAG 424 DNA can provide evidence for enterprises to crack down on counterfeiting, helping enterprises safeguard their legitimate rights and interests. According to the measured data, after applying NTAG 424 DNA, the loss costs caused by the inflow of counterfeit biologics for enterprises decreased by 80% on average. For example, a biopharmaceutical enterprise in Europe reduced the loss caused by counterfeits from 5 million US dollars per year to 1 million US dollars per year after applying NTAG 424 DNA. This shows that the accurate traceability function of NTAG 424 DNA can effectively curb the inflow of counterfeit biologics, reduce loss costs, and protect the interests of enterprises and patients. The comprehensive effect of NTAG 424 DNA in reducing temperature-related failures and counterfeit-related losses makes it an important guarantee for enterprises to reduce the loss rate of cross-border biologics.
Why Choose Mytopband？
- Rich experience in the production of NFC Bible gifts: We mass-produce NFC Bible car pendant, NFC Bible bracelets, NFC Bible hats, NFC Bible keychains and other products, helping customers win a huge market and receiving unanimous praise from users.
- Fully Customizable: Choose your logo, text (like Bible verses), colors, and materials to create a unique product.
- Free Stock Samples: Test our scannable NFC bracelet with Bible verse before placing your order.
- Low MOQ as 500pcs: Perfect for startups and small businesses.
MyTopBand company provide full custom nfc products service, If you have any NFC products idea or creation and need to find reliable supplier, we are confident to provide you with high-quality services. Please find us: www.mytopband.com, or send message to info@mytopband.com, we will reply you within 24 hours.